Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Long Ideas

Long Ideas

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Long Ideas
  • Movers
  • Trading Ideas

Why Novavax Stock Is Moving Today

By Henry Khederian
Today, 9:30 AM
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 9.8% at $230.25 Monday morning after the company announced positive Phase 3 trial results for its COVID-19 vaccine. 

NVAX

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Long Ideas
  • Movers
  • News
  • Small Cap
  • Trading Ideas

iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK

By Vandana Singh
Today, 9:30 AM
iTeos Therapeutics (NASDAQ:ITOS) and GlaxoSmithKline plc (NYSE:GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody. Under the terms of…

GSK

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Long Ideas
  • Movers
  • News
  • Trading Ideas

Sorrento Therapeutics Starts Large Efficacy Trial For Intranasal COVID-19 Antibody In UK

By Vandana Singh
Today, 9:30 AM
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) signed off Sorrento Therapeutics Inc’s (NASDAQ:SRNE) Phase 2 trial evaluating COVI-DROPS in…

SRNE

Read More
2 minute read
  • Long Ideas
  • Media
  • News
  • Tech
  • Trading Ideas

Chip Shortage Bringing Record Business For Supply-Chain Intermediaries Avnet, Arrow Electronics: WSJ

By Rachit Vats
Today, 9:30 AM
The ongoing global semiconductor shortage is boosting business opportunities for semiconductor industry intermediaries, or authorized distributors, as they are able to source parts faster, according to the WSJ report.

AAPL

Read More
2 minute read
  • Fintech
  • Long Ideas
  • News
  • Small Cap
  • Trading Ideas

Is This SPAC Stock One To Watch As Naftali Bennett Becomes Israel’s New Prime Minister?

By Rachit Vats
Today, 9:30 AM
FTAC Olympus Acquisition Corp (NASDAQ: FTOC), the blank-check firm which is set to take Payoneer public later this year could be under investors' radar on Monday as Israel’s new Prime Minister Naftali Bennett is

FTOC

Read More
3 minute read
  • Long Ideas
  • Short Ideas
  • Technicals
  • Trading Ideas

Worth A Gamble? 2 Casino Stocks That Could See Upside

By Melanie Schaffer
Today, 9:30 AM
On June 1, Las Vegas lifted most of its COVID-19 restrictions and its hotels and casinos have been welcoming back guests to dine, shop and gamble with few restrictions.

LVS

Read More
3 minute read
  • Cryptocurrency
  • Long Ideas
  • Markets
  • Short Ideas
  • Trading Ideas

Benzinga’s Bulls And Bears Of The Week: Apple, Amazon, Biogen, Bitcoin, Tesla And More

By Nelson Hem
Today, 9:30 AM
Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the e-commerce leader, a top biotech and the airlines.

AAPL

Read More
1 minute read
  • After-Hours Center
  • Long Ideas
  • Markets
  • News
  • Short Ideas
  • Trading Ideas

Nvidia And Dollar Tree Lead The Nasdaq In A Mixed Day For The Markets

By Henry Khederian
Today, 9:30 AM
U.S. indices had another mixed day of trading following worse-than-expected U.S. jobless figures and inflation data released Thursday. 

BIDU

Read More
2 minute read
  • Cryptocurrency
  • Long Ideas
  • Markets
  • Short Ideas
  • Technicals
  • Trading Ideas

Bitcoin Chops, But Could Be Prepping For A Move

By Melanie Schaffer
Today, 9:30 AM
Bitcoin (CRYPTO: BTC) fell off a cliff on March 12 after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk announced on Twitte

TSLA

Read More
2 minute read
  • Cryptocurrency
  • Long Ideas
  • Markets
  • Short Ideas
  • Technicals
  • Trading Ideas

Could Dogecoin Be Due For A Drop? Here’s What The Chart Says

By Tyler Bundy
Today, 9:30 AM
Dogecoin (CRYPTO:DOGE) is the frontrunner in the cryptocurrency meme world and is one of Elon Musk's favorite cryptos.

COIN

Posts navigation

Previous 1 … 445 446 447 … 455 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service